ArticleJournal of vascular and interventional radiology : JVIR2018

Transarterial Chemoembolization within First 3 Months of Sorafenib Initiation Improves Overall Survival in Hepatocellular Carcinoma: A Retrospective, Multi-Institutional Study with Propensity Matching.

David E Kaplan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.